Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 9.88
-0.27 (-2.66%)
Jun 10, 2026, 11:58 AM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 10.77 billion as of June 9, 2026. Its market cap has increased by 98.38% in one year.
Market Cap
10.77B
Enterprise Value
8.66B
Revenue
2.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.88
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 10.77B, a decrease of -31.34%. That is a compound annual growth rate of -4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 10.77B | -4.16% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 16.14B |
| Metis TechBio | 15.14B |
| Zai Lab | 14.51B |
| TransThera Sciences (Nanjing) | 13.61B |
| Ascentage Pharma Group International | 12.45B |
| Nanjing Leads Biolabs | 11.49B |
| TenNor Therapeutics (Suzhou) | 11.08B |
| Everest Medicines | 9.83B |